Global Aflibercept Biosimilars Market Report, History and Forecast 2018-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,350	138 Pages	QYResearch Group	November, 2023	QYR18353140

Best Price Guarantee
Price	from $3,350
Length	138 Pages
Publisher	QYResearch Group
Published Date	November, 2023
SKU	QYR18353140

Global Aflibercept Biosimilars Market Report, History and Forecast 2018-2029

The global market for Aflibercept Biosimilars was estimated at US$ 9869.64 million in the year 2022, is projected to reach a revised size of US$ 10399.94 million by 2029, growing at a CAGR of 1.41 % during the forecast period 2023-2029.

North American market for Aflibercept Biosimilars was valued at $ 7639.71 million in 2022 and will reach $ 8459.36 million by 2029, at a CAGR of 1.74 % during the forecast period of 2023 through 2029.

Asia-Pacific market for Aflibercept Biosimilars was valued at $ 436.24million in 2022 and will reach $ 384.96 million by 2029, at a CAGR of -2.22% during the forecast period of 2023 through 2029.

Europe market for Aflibercept Biosimilars was valued at $ 1753.49 million in 2022 and will reach $ 1537.67 million by 2029, at a CAGR of 0.78% during the forecast period of 2023 through 2029.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Aflibercept Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aflibercept Biosimilars.

The Aflibercept Biosimilars market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Aflibercept Biosimilars market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aflibercept Biosimilars market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation

This report covers the Aflibercept Biosimilars segments by manufacturers, by Type, by Application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2018-2022, 2023-2029), considering 2022 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

By Company

Regeneron Pharmaceuticals

Bayer HealthCare

Kanghong Pharma

Biocon

Segment by Type

2mg

8mg

Segment by Application

Hospitals

Clinics

Others

By Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

Southeast Asia

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter Two: Detailed analysis of Aflibercept Biosimilars manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Three: Sales, revenue of Aflibercept Biosimilars in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.

Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Analysis of sales channel, distributors and customers.

Chapter Thirteen: Research Findings and Conclusion.

1 Aflibercept Biosimilars Market Overview: 1.1 Aflibercept Biosimilars Product Overview; 1.2 Aflibercept Biosimilars Market By Type; 1.2.1 2mg; 1.2.2 8mg; 1.3 Global Aflibercept Biosimilars Market Size By Type; 1.3.1 Global Aflibercept Biosimilars Market Size Overview By Type (2018-2029); 1.3.2 Global Aflibercept Biosimilars Historic Market Size Review By Type (2018-2023); 1.3.3 Global Aflibercept Biosimilars Forecasted Market Size By Type (2024-2029); 1.4 Key Regions Market Size By Type; 1.4.1 North America Aflibercept Biosimilars Sales Breakdown By Type (2018-2023); 1.4.2 Europe Aflibercept Biosimilars Sales Breakdown By Type (2018-2023); 1.4.3 Asia-pacific Aflibercept Biosimilars Sales Breakdown By Type (2018-2023); 1.4.4 Latin America Aflibercept Biosimilars Sales Breakdown By Type (2018-2023); 1.4.5 Middle East And Africa Aflibercept Biosimilars Sales Breakdown By Type (2018-2023)
2 Aflibercept Biosimilars Market Competition By Company: 2.1 Global Top Players By Aflibercept Biosimilars Sales (2018-2023); 2.2 Global Top Players By Aflibercept Biosimilars Revenue (2018-2023); 2.3 Global Top Players By Aflibercept Biosimilars Price (2018-2023); 2.4 Global Top Manufacturers Aflibercept Biosimilars Manufacturing Base Distribution, Sales Area, Product Type; 2.5 Aflibercept Biosimilars Market Competitive Situation And Trends; 2.5.1 Aflibercept Biosimilars Market Concentration Rate (2018-2023); 2.5.2 Global Largest Manufacturers By Aflibercept Biosimilars Sales And Revenue In 2022; 2.6 Global Top Manufacturers By Company Type (Tier 1, Tier 2, And Tier 3) & (Based On The Revenue In Aflibercept Biosimilars As Of 2022); 2.7 Date Of Key Manufacturers Enter Into Aflibercept Biosimilars Market; 2.8 Key Manufacturers Aflibercept Biosimilars Product Offered; 2.9 Mergers & Acquisitions, Expansion
3 Aflibercept Biosimilars Status And Outlook By Region: 3.1 Global Aflibercept Biosimilars Market Size And Cagr By Region: 2018 Vs 2022 Vs 2029; 3.2 Global Aflibercept Biosimilars Historic Market Size By Region; 3.2.1 Global Aflibercept Biosimilars Sales In Volume By Region (2018-2023); 3.2.2 Global Aflibercept Biosimilars Sales In Value By Region (2018-2023); 3.2.3 Global Aflibercept Biosimilars Sales (Volume & Value), Price And Gross Margin (2018-2023); 3.3 Global Aflibercept Biosimilars Forecasted Market Size By Region; 3.3.1 Global Aflibercept Biosimilars Sales In Volume By Region (2024-2029); 3.3.2 Global Aflibercept Biosimilars Sales In Value By Region (2024-2029); 3.3.3 Global Aflibercept Biosimilars Sales (Volume & Value), Price And Gross Margin (2024-2029)
4 Aflibercept Biosimilars By Application: 4.1 Aflibercept Biosimilars Market By Application; 4.1.1 Hospitals; 4.1.2 Clinics; 4.1.3 Others; 4.2 Global Aflibercept Biosimilars Market Size By Application; 4.2.1 Global Aflibercept Biosimilars Market Size Overview By Application (2018-2029); 4.2.2 Global Aflibercept Biosimilars Historic Market Size Review By Application (2018-2023); 4.2.3 Global Aflibercept Biosimilars Forecasted Market Size By Application (2024-2029); 4.3 Key Regions Market Size By Application; 4.3.1 North America Aflibercept Biosimilars Sales Breakdown By Application (2018-2023); 4.3.2 Europe Aflibercept Biosimilars Sales Breakdown By Application (2018-2023); 4.3.3 Asia-pacific Aflibercept Biosimilars Sales Breakdown By Application (2018-2023); 4.3.4 Latin America Aflibercept Biosimilars Sales Breakdown By Application (2018-2023); 4.3.5 Middle East And Africa Aflibercept Biosimilars Sales Breakdown By Application (2018-2023)
5 North America Aflibercept Biosimilars By Country: 5.1 North America Aflibercept Biosimilars Historic Market Size By Country; 5.1.1 North America Aflibercept Biosimilars Market Size Growth Rate (Cagr) By Country: 2018 Vs 2022 Vs 2029; 5.1.2 North America Aflibercept Biosimilars Sales In Volume By Country (2018-2023); 5.1.3 North America Aflibercept Biosimilars Sales In Value By Country (2018-2023); 5.2 North America Aflibercept Biosimilars Forecasted Market Size By Country; 5.2.1 North America Aflibercept Biosimilars Sales In Volume By Country (2024-2029); 5.2.2 North America Aflibercept Biosimilars Sales In Value By Country (2024-2029)
6 Europe Aflibercept Biosimilars By Country: 6.1 Europe Aflibercept Biosimilars Historic Market Size By Country; 6.1.1 Europe Aflibercept Biosimilars Market Size Growth Rate (Cagr) By Country: 2018 Vs 2022 Vs 2029; 6.1.2 Europe Aflibercept Biosimilars Sales In Volume By Country (2018-2023); 6.1.3 Europe Aflibercept Biosimilars Sales In Value By Country (2018-2023); 6.2 Europe Aflibercept Biosimilars Forecasted Market Size By Country; 6.2.1 Europe Aflibercept Biosimilars Sales In Volume By Country (2024-2029); 6.2.2 Europe Aflibercept Biosimilars Sales In Value By Country (2024-2029)
7 Asia-pacific Aflibercept Biosimilars By Region: 7.1 Asia-pacific Aflibercept Biosimilars Historic Market Size By Region; 7.1.1 Asia-pacific Aflibercept Biosimilars Market Size Growth Rate (Cagr) By Region: 2018 Vs 2022 Vs 2029; 7.1.2 Asia-pacific Aflibercept Biosimilars Sales In Volume By Region (2018-2023); 7.1.3 Asia-pacific Aflibercept Biosimilars Sales In Value By Region (2018-2023); 7.2 Asia-pacific Aflibercept Biosimilars Forecasted Market Size By Region; 7.2.1 Asia-pacific Aflibercept Biosimilars Sales In Volume By Region (2024-2029); 7.2.2 Asia-pacific Aflibercept Biosimilars Sales In Value By Region (2024-2029)
8 Latin America Aflibercept Biosimilars By Country: 8.1 Latin America Aflibercept Biosimilars Historic Market Size By Country; 8.1.1 Latin America Aflibercept Biosimilars Market Size Growth Rate (Cagr) By Country: 2018 Vs 2022 Vs 2029; 8.1.2 Latin America Aflibercept Biosimilars Sales In Volume By Country (2018-2023); 8.1.3 Latin America Aflibercept Biosimilars Sales In Value By Country (2018-2023); 8.2 Latin America Aflibercept Biosimilars Forecasted Market Size By Country; 8.2.1 Latin America Aflibercept Biosimilars Sales In Volume By Country (2024-2029); 8.2.2 Latin America Aflibercept Biosimilars Sales In Value By Country (2024-2029)
9 Middle East And Africa Aflibercept Biosimilars By Country: 9.1 Middle East And Africa Aflibercept Biosimilars Historic Market Size By Country; 9.1.1 Middle East And Africa Aflibercept Biosimilars Market Size Growth Rate (Cagr) By Country: 2018 Vs 2022 Vs 2029; 9.1.2 Middle East And Africa Aflibercept Biosimilars Sales In Volume By Country (2018-2023); 9.1.3 Middle East And Africa Aflibercept Biosimilars Sales In Value By Country (2018-2023); 9.2 Middle East And Africa Aflibercept Biosimilars Forecasted Market Size By Country; 9.2.1 Middle East And Africa Aflibercept Biosimilars Sales In Volume By Country (2024-2029); 9.2.2 Middle East And Africa Aflibercept Biosimilars Sales In Value By Country (2024-2029)
10 Company Profiles: 10.1 Regeneron Pharmaceuticals; 10.1.1 Regeneron Pharmaceuticals Company Information; 10.1.2 Regeneron Pharmaceuticals Introduction And Business Overview; 10.1.3 Regeneron Pharmaceuticals Aflibercept Biosimilars Sales, Revenue And Gross Margin (2018-2023); 10.1.4 Regeneron Pharmaceuticals Aflibercept Biosimilars Products Offered; 10.1.5 Regeneron Pharmaceuticals Recent Development; 10.2 Bayer Healthcare; 10.2.1 Bayer Healthcare Company Information; 10.2.2 Bayer Healthcare Introduction And Business Overview; 10.2.3 Bayer Healthcare Aflibercept Biosimilars Sales, Revenue And Gross Margin (2018-2023); 10.2.4 Bayer Healthcare Aflibercept Biosimilars Products Offered; 10.2.5 Bayer Healthcare Recent Development; 10.3 Kanghong Pharma; 10.3.1 Kanghong Pharma Company Information; 10.3.2 Kanghong Pharma Introduction And Business Overview; 10.3.3 Kanghong Pharma Aflibercept Biosimilars Sales, Revenue And Gross Margin (2018-2023); 10.3.4 Kanghong Pharma Aflibercept Biosimilars Products Offered; 10.3.5 Kanghong Pharma Recent Development; 10.4 Biocon; 10.4.1 Biocon Company Information; 10.4.2 Biocon Introduction And Business Overview; 10.4.3 Biocon Aflibercept Biosimilars Products Offered; 10.4.4 Biocon Recent Development; 10.5 Abbvie; 10.5.1 Abbvie Company Information; 10.5.2 Abbvie Introduction And Business Overview; 10.5.3 Abbvie Aflibercept Biosimilars Products Offered; 10.5.4 Abbvie Recent Development; 10.6 Roche; 10.6.1 Roche Company Information; 10.6.2 Roche Introduction And Business Overview; 10.6.3 Roche Aflibercept Biosimilars Products Offered; 10.6.4 Roche Recent Development; 10.7 Novartis; 10.7.1 Novartis Company Information; 10.7.2 Novartis Introduction And Business Overview; 10.7.3 Novartis Aflibercept Biosimilars Products Offered; 10.7.4 Novartis Recent Development; 10.8 Qilu Pharmaceutical; 10.8.1 Qilu Pharmaceutical Company Information; 10.8.2 Qilu Pharmaceutical Introduction And Business Overview; 10.8.3 Qilu Pharmaceutical Aflibercept Biosimilars Products Offered; 10.8.4 Qilu Pharmaceutical Recent Development; 10.9 Regenxbio; 10.9.1 Regenxbio Company Information; 10.9.2 Regenxbio Introduction And Business Overview; 10.9.3 Regenxbio Aflibercept Biosimilars Products Offered; 10.9.4 Regenxbio Recent Development; 10.10 Samsung Bioepis; 10.10.1 Samsung Bioepis Company Information; 10.10.2 Samsung Bioepis Introduction And Business Overview; 10.10.3 Samsung Bioepis Aflibercept Biosimilars Products Offered; 10.10.4 Samsung Bioepis Recent Development; 10.11 Amgen; 10.11.1 Amgen Company Information; 10.11.2 Amgen Introduction And Business Overview; 10.11.3 Amgen Aflibercept Biosimilars Products Offered; 10.12 Formycon; 10.12.1 Formycon Company Information; 10.12.2 Formycon Introduction And Business Overview; 10.12.3 Formycon Aflibercept Biosimilars Products Offered; 10.12.4 Formycon Recent Development
11 Opportunities, Challenges, Risks And Influences Factors Analysis: 11.1 Aflibercept Biosimilars Industrial Chain Analysis; 11.2 Aflibercept Biosimilars Market Dynamics; 11.2.1 Aflibercept Biosimilars Industry Trends; 11.2.2 Aflibercept Biosimilars Market Drivers; 11.2.3 Aflibercept Biosimilars Market Challenges; 11.2.4 Aflibercept Biosimilars Market Restraints
12 Marketing Strategy Analysis, Distributors: 12.1 Sales Channel; 12.2 Aflibercept Biosimilars Distributors; 12.3 Aflibercept Biosimilars Downstream Customers
13 Research Findings And Conclusion
14 Appendix: 14.1 Research Methodology; 14.1.1 Methodology/Research Approach; 14.1.2 Data Source; 14.2 Author Details; 14.3 Disclaimer; List Of Tables; Table 1. Major Company Of 2mg; Table 2. Major Company Of 8mg; Table 3. Global Aflibercept Biosimilars Sales By Type: 2018 Vs 2022 Vs 2029 (Us$ Million); Table 4. Global Aflibercept Biosimilars Sales By Type (2018-2023) & (K Units); Table 5. Global Aflibercept Biosimilars Sales Market Share In Volume By Type (2018-2023); Table 6. Global Aflibercept Biosimilars Sales By Type (2018-2023) & (Us$ Million); Table 7. Global Aflibercept Biosimilars Sales Market Share In Value By Type (2018-2023); Table 8. Global Aflibercept Biosimilars Price By Type (2018-2023) & (Us$/Unit); Table 9. Global Aflibercept Biosimilars Sales By Type (2024-2029) & (K Units); Table 10. Global Aflibercept Biosimilars Sales Market Share In Volume By Type (2024-2029); Table 11. Global Aflibercept Biosimilars Sales By Type (2024-2029) & (Us$ Million); Table 12. Global Aflibercept Biosimilars Sales Market Share In Value By Type (2024-2029); Table 13. Global Aflibercept Biosimilars Price By Type (2024-2029) & (Us$/Unit); Table 14. North America Aflibercept Biosimilars Sales By Type (2018-2023) & (K Units); Table 15. North America Aflibercept Biosimilars Sales By Type (2018-2023) & (Us$ Million); Table 16. Europe Aflibercept Biosimilars Sales (K Units) By Type (2018-2023); Table 17. Europe Aflibercept Biosimilars Sales By Type (2018-2023) & (Us$ Million); Table 18. Asia-pacific Aflibercept Biosimilars Sales (K Units) By Type (2018-2023); Table 19. Asia-pacific Aflibercept Biosimilars Sales By Type (2018-2023) & (Us$ Million); Table 20. Latin America Aflibercept Biosimilars Sales (K Units) By Type (2018-2023)